Rayhane Nchioua

1.2k total citations
16 papers, 338 citations indexed

About

Rayhane Nchioua is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Rayhane Nchioua has authored 16 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 8 papers in Immunology and 5 papers in Epidemiology. Recurrent topics in Rayhane Nchioua's work include SARS-CoV-2 and COVID-19 Research (8 papers), interferon and immune responses (7 papers) and HIV Research and Treatment (4 papers). Rayhane Nchioua is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), interferon and immune responses (7 papers) and HIV Research and Treatment (4 papers). Rayhane Nchioua collaborates with scholars based in Germany, United States and United Kingdom. Rayhane Nchioua's co-authors include Frank Kirchhoff, Konstantin M. J. Sparrer, Dorota Kmieć, Steffen Stenger, Daniel Sauter, Jan Münch, Rüdiger Groß, Janis A. Müller, Carina Conzelmann and Chad M. Swanson and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Virology.

In The Last Decade

Rayhane Nchioua

15 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rayhane Nchioua Germany	8	159	150	105	64	49	16	338
Kin Kui Lai United States	9	139 0.9×	209 1.4×	114 1.1×	125 2.0×	29 0.6×	12	419
Markus Mukenhirn Germany	7	104 0.7×	221 1.5×	88 0.8×	40 0.6×	21 0.4×	9	367
Wenzhuo Hao United States	14	148 0.9×	140 0.9×	115 1.1×	105 1.6×	13 0.3×	20	427
Batsheva Rozman Israel	6	72 0.5×	114 0.8×	164 1.6×	97 1.5×	11 0.2×	7	327
Nina Hertoghs United States	7	213 1.3×	72 0.5×	106 1.0×	53 0.8×	91 1.9×	17	346
Keaton M. Crosse Australia	8	146 0.9×	76 0.5×	145 1.4×	59 0.9×	10 0.2×	9	343
Annie Bernier Canada	6	62 0.4×	123 0.8×	109 1.0×	40 0.6×	33 0.7×	7	278
Melissa Belló-Pérez Spain	11	179 1.1×	108 0.7×	89 0.8×	65 1.0×	12 0.2×	30	338
Chenglong Sun China	5	317 2.0×	133 0.9×	189 1.8×	170 2.7×	34 0.7×	13	476
Michela Masetti Italy	7	71 0.4×	53 0.4×	70 0.7×	54 0.8×	68 1.4×	9	239

Countries citing papers authored by Rayhane Nchioua

Since Specialization

Citations

This map shows the geographic impact of Rayhane Nchioua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rayhane Nchioua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rayhane Nchioua more than expected).

Fields of papers citing papers by Rayhane Nchioua

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rayhane Nchioua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rayhane Nchioua. The network helps show where Rayhane Nchioua may publish in the future.

Co-authorship network of co-authors of Rayhane Nchioua

This figure shows the co-authorship network connecting the top 25 collaborators of Rayhane Nchioua. A scholar is included among the top collaborators of Rayhane Nchioua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rayhane Nchioua. Rayhane Nchioua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Zech, Fabian, Rayhane Nchioua, Christoph Jung, et al.. (2025). Role of N-linked glycosylation sites in human ACE2 in SARS-CoV-2 and hCoV-NL63 infection. Journal of Virology. 99(5). e0220224–e0220224.

Nchioua, Rayhane, Dorota Kmieć, Frédéric Bibollet‐Ruche, et al.. (2025). Host ZAP activity correlates with the levels of CpG suppression in primate lentiviruses. Proceedings of the National Academy of Sciences. 122(15). e2419489122–e2419489122. 3 indexed citations

Volčič, Meta, Rayhane Nchioua, Fabian Zech, et al.. (2024). Attenuated replication and damaging effects of SARS‐CoV‐2 Omicron variants in an intestinal epithelial barrier model. Journal of Medical Virology. 96(7). e29783–e29783. 4 indexed citations

Nchioua, Rayhane, et al.. (2024). A Gaussia luciferase reporter assay for the evaluation of coronavirus Nsp5/3CLpro activity. Scientific Reports. 14(1). 20697–20697. 1 indexed citations

Bozzo, Caterina Prelli, Dorota Kmieć, Rayhane Nchioua, et al.. (2023). Endogenous IFITMs boost SARS-coronavirus 1 and 2 replication whereas overexpression inhibits infection by relocalizing ACE2. iScience. 26(4). 106395–106395. 9 indexed citations

Kmieć, Dorota, Dan Hu, Rayhane Nchioua, et al.. (2023). Tetherin Restricts SARS-CoV-2 despite the Presence of Multiple Viral Antagonists. Viruses. 15(12). 2364–2364. 7 indexed citations

Nchioua, Rayhane, Susanne Klute, Lennart Koepke, et al.. (2023). Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1. Life Science Alliance. 6(6). e202201745–e202201745. 12 indexed citations

Nchioua, Rayhane, et al.. (2023). Impact of mutations defining SARS-CoV-2 Omicron subvariants BA.2.12.1 and BA.4/5 on Spike function and neutralization. iScience. 26(11). 108299–108299. 5 indexed citations

Schmidt, Hanna, Alexander Sauter, Fabian Zech, et al.. (2022). Serially passaged, conditionally reprogrammed nasal epithelial cells as a model to study epithelial functions and SARS-CoV-2 infection. American Journal of Physiology-Cell Physiology. 322(4). C591–C604. 3 indexed citations

10.

Acharya, Dhiraj, Meta Volčič, Guanqun Liu, et al.. (2022). Actin cytoskeleton remodeling primes RIG-I-like receptor activation. Cell. 185(19). 3588–3602.e21. 45 indexed citations

11.

Nchioua, Rayhane, Dorota Kmieć, Caterina Prelli Bozzo, et al.. (2022). SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells. Journal of Virology. 96(11). e0059422–e0059422. 25 indexed citations

12.

Nchioua, Rayhane, Dorota Kmieć, Christina M. Stürzel, et al.. (2021). APOBEC3F Constitutes a Barrier to Successful Cross-Species Transmission of Simian Immunodeficiency Virus SIVsmm to Humans. Journal of Virology. 95(17). e0080821–e0080821. 4 indexed citations

13.

Tripathi, Utkarsh, Rayhane Nchioua, Larissa Prata, et al.. (2021). SARS-CoV-2 causes senescence in human cells and exacerbates the senescence-associated secretory phenotype through TLR-3. Aging. 13(18). 21838–21854. 60 indexed citations

14.

Nchioua, Rayhane, Dorota Kmieć, Janis A. Müller, et al.. (2020). SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans. mBio. 11(5). 92 indexed citations

15.

Kmieć, Dorota, Rayhane Nchioua, Scott Sherrill-Mix, et al.. (2020). CpG Frequency in the 5′ Third of the env Gene Determines Sensitivity of Primary HIV-1 Strains to the Zinc-Finger Antiviral Protein. mBio. 11(1). 44 indexed citations

16.

Nchioua, Rayhane, Matteo Bosso, Dorota Kmieć, & Frank Kirchhoff. (2020). Cellular Factors Targeting HIV-1 Transcription and Viral RNA Transcripts. Viruses. 12(5). 495–495. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact